102 related articles for article (PubMed ID: 19508870)
1. TOE1 interacts with p53 to modulate its transactivation potential.
Sperandio S; Tardito S; Surzycki A; Latterich M; de Belle I
FEBS Lett; 2009 Jul; 583(13):2165-70. PubMed ID: 19508870
[TBL] [Abstract][Full Text] [Related]
2. Human Spot 14 protein is a p53-dependent transcriptional coactivator via the recruitment of thyroid receptor and Zac1.
Chou WY; Ho CL; Tseng ML; Liu ST; Yen LC; Huang SM
Int J Biochem Cell Biol; 2008; 40(9):1826-34. PubMed ID: 18299245
[TBL] [Abstract][Full Text] [Related]
3. SEI family of nuclear factors regulates p53-dependent transcriptional activation.
Watanabe-Fukunaga R; Iida S; Shimizu Y; Nagata S; Fukunaga R
Genes Cells; 2005 Aug; 10(8):851-60. PubMed ID: 16098148
[TBL] [Abstract][Full Text] [Related]
4. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
[TBL] [Abstract][Full Text] [Related]
5. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
Shinmura K; Bennett RA; Tarapore P; Fukasawa K
Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
[TBL] [Abstract][Full Text] [Related]
6. Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization.
Hanson S; Kim E; Deppert W
Oncogene; 2005 Feb; 24(9):1641-7. PubMed ID: 15674341
[TBL] [Abstract][Full Text] [Related]
7. [Prothymosin alpha interacts with C-terminal domain of histone H1 and dissociates p53-histone H1 complex].
Zakharova NI; Sokolov VV; Suvorova AA; Shiau AI; Wu CL; Efstaf'eva AG
Mol Biol (Mosk); 2011; 45(4):679-88. PubMed ID: 21954601
[TBL] [Abstract][Full Text] [Related]
8. The transactivation domain of heterogeneous nuclear ribonucleoprotein K overlaps its nuclear shuttling domain.
Chan JY; Huang SM; Liu ST; Huang CH
Int J Biochem Cell Biol; 2008; 40(10):2078-89. PubMed ID: 18346927
[TBL] [Abstract][Full Text] [Related]
9. Latent and active p53 are identical in conformation.
Ayed A; Mulder FA; Yi GS; Lu Y; Kay LE; Arrowsmith CH
Nat Struct Biol; 2001 Sep; 8(9):756-60. PubMed ID: 11524676
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcription.
Sieber T; Dobner T
J Virol; 2007 Jan; 81(1):95-105. PubMed ID: 17050591
[TBL] [Abstract][Full Text] [Related]
11. The intracellular domain of the amyloid precursor protein (AICD) enhances the p53-mediated apoptosis.
Ozaki T; Li Y; Kikuchi H; Tomita T; Iwatsubo T; Nakagawara A
Biochem Biophys Res Commun; 2006 Dec; 351(1):57-63. PubMed ID: 17054906
[TBL] [Abstract][Full Text] [Related]
12. FHL2 mediates p53-induced transcriptional activation through a direct association with HIPK2.
Lee SW; Kim EJ; Um SJ
Biochem Biophys Res Commun; 2006 Jan; 339(4):1056-62. PubMed ID: 16343438
[TBL] [Abstract][Full Text] [Related]
13. Structure of the human p53 core domain in the absence of DNA.
Wang Y; Rosengarth A; Luecke H
Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):276-81. PubMed ID: 17327663
[TBL] [Abstract][Full Text] [Related]
14. Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis.
Park K; Kim K; Rho SB; Choi K; Kim D; Oh SH; Park J; Lee SH; Lee JH
Cancer Res; 2005 Feb; 65(3):749-57. PubMed ID: 15705871
[TBL] [Abstract][Full Text] [Related]
15. Biological function of the vaccinia virus Z-DNA-binding protein E3L: gene transactivation and antiapoptotic activity in HeLa cells.
Kwon JA; Rich A
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12759-64. PubMed ID: 16126896
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer amplified sequence 2, a novel negative regulator of the p53 tumor suppressor.
Kuo PC; Tsao YP; Chang HW; Chen PH; Huang CW; Lin ST; Weng YT; Tsai TC; Shieh SY; Chen SL
Cancer Res; 2009 Dec; 69(23):8877-85. PubMed ID: 19903847
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of the interface between nucleophosmin (NPM) and p53: potential role in p53 stabilisation.
Lambert B; Buckle M
FEBS Lett; 2006 Jan; 580(1):345-50. PubMed ID: 16376884
[TBL] [Abstract][Full Text] [Related]
18. S100A6 binds p53 and affects its activity.
Słomnicki ŁP; Nawrot B; Leśniak W
Int J Biochem Cell Biol; 2009 Apr; 41(4):784-90. PubMed ID: 18765292
[TBL] [Abstract][Full Text] [Related]
19. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.
Cano CE; Gommeaux J; Pietri S; Culcasi M; Garcia S; Seux M; Barelier S; Vasseur S; Spoto RP; Pébusque MJ; Dusetti NJ; Iovanna JL; Carrier A
Cancer Res; 2009 Jan; 69(1):219-26. PubMed ID: 19118006
[TBL] [Abstract][Full Text] [Related]
20. Target structure-based discovery of small molecules that block human p53 and CREB binding protein association.
Sachchidanand ; Resnick-Silverman L; Yan S; Mutjaba S; Liu WJ; Zeng L; Manfredi JJ; Zhou MM
Chem Biol; 2006 Jan; 13(1):81-90. PubMed ID: 16426974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
